Cytokines profile of reverse cardiac remodeling following transcatheter aortic valve replacement-Reference-Cited by-同舟云学术

Cytokines profile of reverse cardiac remodeling following transcatheter aortic valve replacement

Published:2018-11 Issue: Volume:270 Page:83-88
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Kim Juyong Brian,Kobayashi Yukari,Kuznetsova Tatiana,Moneghetti Kegan J.,Brenner Daniel A.,O'Malley Ryan,Dao Catherine,Wu Joseph C.,Fischbein Michael,Craig Miller D.,Yeung Alan C.,Liang David,Haddad Francois,Fearon William F.

Funder

NIH

Translational Research and Applied Medicine

Women's Sex-Difference in Medicine

Pai Chan Lee Research Fund

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?;Kupari;Eur. Heart J.,2005

2. Left ventricular hypertrophy in isolated aortic stenosis: primetime for the ventricle;Gavina;Curr. Pharm. Biotechnol.,2012

3. Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice;Woldbaek;Am. J. Physiol. Heart Circ. Physiol.,2005

4. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-akt-gata4 signaling pathway in cardiomyocytes;Chandrasekar;J. Biol. Chem.,2005

5. The effect of daily administration of il-18 on cardiac structure and function;Platis;Perfusion,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Left ventricular reverse remodeling after transcatheter aortic valve replacement for predominant aortic stenosis and mixed aortic valve disease;Journal of Clinical Ultrasound;2023-10-25

2. Determinants and treatments of heart failure after transcatheter aortic valve implantation: moving up a notch;ESC Heart Failure;2023-07-10

3. Contemporary issues and lifetime management in patients underwent transcatheter aortic valve replacement;Cardiovascular Intervention and Therapeutics;2023-03-21

4. Left Ventricular Systolic Dysfunction in Aortic Stenosis: Pathophysiology, Diagnosis, Management, and Future Directions;Structural Heart;2022-10

5. Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?;Journal of Clinical Laboratory Analysis;2021-09-25